Literature DB >> 24531877

RASAL1 influences the proliferation and invasion of gastric cancer cells by regulating the RAS/ERK signaling pathway.

Hong Chen1, Zheng-Yuan Cheng, Ying Pan, Zhi Wang, Yang Liu, Jin-Qi Zhang.   

Abstract

The aim of this study was to investigate the biological characteristics of the RASAL1 gene in a well-differentiated gastric cancer cell line MKN-28 and a poorly differentiated gastric cancer cell line BGC-823 cells, using RNA interference and gene transfection technology, respectively. MKN-28 cells were transfected with the shRNA of RASAL1 and BGC-823 cells were transfected with the pcDNA 3.1 plasmid vector containing RASAL1. RT-PCR and western blotting were then used to detect the expression of RASAL1 mRNA and protein. The activities of RAS and extracellular signal-regulated kinase 1/2 were analyzed by the pull-down method and western blotting. The proliferate capacity, apoptosis rate, invasive and migratory potentials of MKN-28 or BGC-823 cells were also measured by Cell Counting Kit-8 cell proliferation assay, propidium iodide/Annexin V staining coupled with flow cytometry, and transwell chamber assays, respectively. Measurement of RASAL1 mRNA and protein expression in two cells revealed successful transfection of the shRNA of RASAL1 and RASAL1-pcDNA3.1 plasmid into these two cells. Moreover, decreased expression of RASAL1 in MKN-28 cells resulted in increased expression of RAS-GTP and p-ERK1/2. Interestingly, decreased expression of RASAL1 inhibited apoptosis and facilitated cell proliferation, invasion and migration. The increased expression of RASAL1 in BGC-823 cells caused declined expression of RAS-GTP and p-ERK1/2, as well as promoted apoptosis and restrained cell proliferation, invasion and migration. The down-regulation of RASAL1 promoted the proliferation, invasion and migration of gastric cancer MKN-28 cells, and up-regulation of RASAL1 inhibited the proliferation, invasion and migration of BGC-823 gastric cancer cells by regulating the RAS/ERK signaling pathway. Thus, our results suggest that RASAL1 may play an important role as a tumor suppressor gene in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531877     DOI: 10.1007/s13577-014-0090-2

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  24 in total

1.  Enforced expression of RASAL1 suppresses cell proliferation and the transformation ability of gastric cancer cells.

Authors:  Fengchang Qiao; Xianwei Su; Xuemei Qiu; Danwen Qian; Xiao Peng; Hong Chen; Zhujiang Zhao; Hong Fan
Journal:  Oncol Rep       Date:  2012-07-19       Impact factor: 3.906

2.  NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome.

Authors:  Michael Hölzel; Sidong Huang; Jan Koster; Ingrid Ora; Arjan Lakeman; Huib Caron; Wouter Nijkamp; Jing Xie; Tom Callens; Shahab Asgharzadeh; Robert C Seeger; Ludwine Messiaen; Rogier Versteeg; René Bernards
Journal:  Cell       Date:  2010-07-23       Impact factor: 41.582

Review 3.  Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?

Authors:  Dominico Vigil; Jacqueline Cherfils; Kent L Rossman; Channing J Der
Journal:  Nat Rev Cancer       Date:  2010-11-24       Impact factor: 60.716

4.  K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia.

Authors:  Tomoyuki Okumura; Russell E Ericksen; Shigeo Takaishi; Sophie S W Wang; Zinaida Dubeykovskiy; Wataru Shibata; Kelly S Betz; Sureshkuma Muthupalani; Arlin B Rogers; James G Fox; Anil K Rustgi; Timothy C Wang
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

5.  Inactivation of Ras GTPase-activating proteins promotes unrestrained activity of wild-type Ras in human liver cancer.

Authors:  Diego F Calvisi; Sara Ladu; Elizabeth A Conner; Daekwan Seo; Jer-Tsong Hsieh; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Hepatol       Date:  2010-09-07       Impact factor: 25.083

Review 6.  Deciphering the underlying genetic and epigenetic events leading to gastric carcinogenesis.

Authors:  Paraskevi Vogiatzi; Carla Vindigni; Franco Roviello; Alessandra Renieri; Antonio Giordano
Journal:  J Cell Physiol       Date:  2007-05       Impact factor: 6.384

Review 7.  Biomarkers downstream of RAS: a search for robust transcriptional targets.

Authors:  Balazs Györffy; Reinhold Schäfer
Journal:  Curr Cancer Drug Targets       Date:  2010-12       Impact factor: 3.428

8.  Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression.

Authors:  Miki Ohta; Motoko Seto; Hideaki Ijichi; Koji Miyabayashi; Yotaro Kudo; Dai Mohri; Yoshinari Asaoka; Motohisa Tada; Yasuo Tanaka; Tsuneo Ikenoue; Fumihiko Kanai; Takao Kawabe; Masao Omata
Journal:  Gastroenterology       Date:  2008-10-02       Impact factor: 22.682

9.  Mutation detection of KRAS by high-resolution melting analysis in Chinese with gastric cancer.

Authors:  Zhi-Min Liu; Li-Na Liu; Mei Li; Qiu-Ping Zhang; Shi-Hua Cheng; Shen Lu
Journal:  Oncol Rep       Date:  2009-09       Impact factor: 3.906

10.  Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers.

Authors:  Hongchuan Jin; Xian Wang; Jianming Ying; Ada H Y Wong; Yan Cui; Gopesh Srivastava; Zhong-Ying Shen; En-Min Li; Qian Zhang; Jie Jin; Sabine Kupzig; Anthony T C Chan; Peter J Cullen; Qian Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

View more
  11 in total

1.  miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance.

Authors:  Xiaojie Deng; Zhen Liu; Xiong Liu; Qiaofen Fu; Tongyuan Deng; Juan Lu; Yiyi Liu; Zixi Liang; Qingping Jiang; Chao Cheng; Weiyi Fang
Journal:  Mol Ther       Date:  2018-02-03       Impact factor: 11.454

2.  RAS protein activator-like 1 is functionally involved in hypoxia resistance in breast cancer cells by targeting hypoxia inducible factor-1α.

Authors:  Ziming Huang; Rong Wang; Gang Wei; Ran Jiang; Yuan Zheng; Yiwen Tian; Bo Chen; Chunmei Ye; Mingxing Xue; Chunjiao Yu
Journal:  Oncol Lett       Date:  2017-07-21       Impact factor: 2.967

Review 3.  Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer.

Authors:  Mei Yang; Chang-Zhi Huang
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

4.  Asparaginyl endopeptidase promotes the invasion and metastasis of gastric cancer through modulating epithelial-to-mesenchymal transition and analysis of their phosphorylation signaling pathways.

Authors:  Yuehong Cui; Yan Wang; Hong Li; Qian Li; Yiyi Yu; Xiaojing Xu; Bei Xu; Tianshu Liu
Journal:  Oncotarget       Date:  2016-06-07

5.  miR-130b-5p promotes proliferation, migration and invasion of gastric cancer cells via targeting RASAL1.

Authors:  Hong Chen; Yiqiong Yang; Jing Wang; Duo Shen; Jiyi Zhao; Qian Yu
Journal:  Oncol Lett       Date:  2018-03-05       Impact factor: 2.967

6.  K-ras-ERK1/2 down-regulates H2A.XY142ph through WSTF to promote the progress of gastric cancer.

Authors:  Chao Dong; Jing Sun; Sha Ma; Guoying Zhang
Journal:  BMC Cancer       Date:  2019-05-31       Impact factor: 4.638

7.  GTPase-activating protein Rasal1 associates with ZAP-70 of the TCR and negatively regulates T-cell tumor immunity.

Authors:  Youg Raj Thaker; Monika Raab; Klaus Strebhardt; Christopher E Rudd
Journal:  Nat Commun       Date:  2019-10-22       Impact factor: 14.919

8.  RASAL1 induces to downregulate the SCD1, leading to suppression of cell proliferation in colon cancer via LXRα/SREBP1c pathway.

Authors:  Guangchuan Wang; Zhen Li; Xiao Li; Chunqing Zhang; Lipan Peng
Journal:  Biol Res       Date:  2019-12-17       Impact factor: 5.612

Review 9.  Functions of Vertebrate Ferlins.

Authors:  Anna V Bulankina; Sven Thoms
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

10.  Danhong Injection Alleviates Cardiac Fibrosis via Preventing the Hypermethylation of Rasal1 and Rassf1 in TAC Mice.

Authors:  Sinai Li; Ping Li; Weihong Liu; Juju Shang; Shenglei Qiu; Xiang Li; Wei Liu; Haoyue Shi; Mingxue Zhou; Hongxu Liu
Journal:  Oxid Med Cell Longev       Date:  2020-12-29       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.